Workflow
Vertex: Latest Casgevy Data Highlights Efficacy Amid Slow Commercial Launch
Seeking Alpha·2025-07-10 03:09

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ), the Boston-based pharma, have been gathering some momentum since the company shared longer-term data from its studies of its Sickle Cell Disease/transf ...